The approach reduces recovery times and lowers rates of complications
News
Kate Therapeutics and Capsida Biotherapeutics collaborate on gene therapies
The companies aim to bring gene therapies to patients sooner than traditional approaches
NIHR awards £97.5m to fund its new Research Support Service
NIHR awards £97.5m to fund its new Research Support Service
Vortex expands research at London Cancer Hub’s Innovation Gateway
The Cancer Hub aims to create a world-leading ecosystem for cancer research
Fewer MS patients are prescribed DMTs in UK compared to Europe
The study analysed and compared information from 65,000 MS patients
NERA Economic Consulting raises concerns over DHSC’s Statutory Scheme
The proposed changes could limit patients’s access to treatments and clinical trials
Austrian State Secretary to speak at FlyPharma Europe 2023
FlyPharma Europe is an event for the pharma logistics industry, connecting professionals from across the globe
NHS medicines access in jeopardy says ABPI
Review raises concerns about approach taken by the DHSC regarding changes to Statutory Scheme
Women in Life Science Denmark launches leadership drive
Initiative has been designed to support career advancement for women across the life sciences
AstraZeneca and SAS link up on AI and analytics
Collaboration will enable teams across the organisation to increase clinical research innovation
NHS Confederation research supports investment in NHS services
Report shows that if the health service invests in community services hospital admissions will reduce
Oxford Biodynamics launches prostate screening test
EpiSwitch is designed for men with prostate cancer risk in the UK and is 94% accurate
UKHSA reaches vaccine deal with CSL Seqirus
Agreement will provide timely boost to pandemic preparedness against influenza
Seagen and Astellas announce results from EV-302 study
Trial involves the use of Padcev and Keytruda among patients with certain types of urothelial cancer
NICE nod for Darzalex with lenalidomide and dexamethasone
Therapy has been developed to treat adult patients with newly diagnosed multiple myeloma
